See what we’re doing
Animal Life Sciences has licensed multiple drug technologies developed at the M.D. Anderson Cancer Center for the following diseases in animals:
Advanced chemotherapies for the treatment of leukemias and brain tumors
Cell signaling modulators and inhibitors of glycolysis for the treatment of a wide range of tumors
Topical treatments for a wide range of cancerous and noncancerous inflammatory skin conditions
OUR DRUG PIPELINE
Alongside direct investment of $60 million, over $43 million of grant funding (total of $103 million USD) has gone towards the development of our robust drug development pipeline.